Skip to main content

Table 1 Comparison of the clinicopathological parameters between the R + TKI and TKI alone groups

From: Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Parameters

Treatment

P value

R + TKI (N = 65)

TKI alone (N = 67)

Age (mean ± SEM)

70.2 ± 1.115

70.88 ± 1.008

0.65

Gender

 Female

28

27

0.73

 Male

36

40

 No data

1

0

 

Pathological stages

 I

13

8

0.20

 II

16

12

 III

36

47

Nodal status

 N0

18

18

1.00

 N1/N2

47

49

EGFR mutations

 exon 19

54

58

0.86

 exon 20

6

5

 exon 21

6

5

Radiation therapy

 EBRT

61

0

0.99

 SBRT

4

0

  1. EBRT External beam radiation therapy, SBRT Stereotactic body radiation therapy